XML 31 R14.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Balance Sheet Details
3 Months Ended
Jan. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Details Balance Sheet Details
Balance sheet details were as follows:
Cash, cash equivalents and restricted cash
 
As of
 
January 31, 2020
 
October 31, 2019
 
In millions
Cash and cash equivalents
$
3,171

 
$
3,753

Restricted cash(1)
377

 
323

Cash, cash equivalents and restricted cash
$
3,548

 
$
4,076

 

(1) The Company includes Restricted cash in Other current assets in the accompanying Condensed Consolidated Balance Sheets.
Inventory
 
As of
 
January 31, 2020
 
October 31, 2019
 
In millions
Finished goods
$
1,245

 
$
1,198

Purchased parts and fabricated assemblies
1,315

 
1,189

Total
$
2,560

 
$
2,387


Property, Plant and Equipment
 
As of
 
January 31, 2020
 
October 31, 2019
 
In millions
Land
$
90

 
$
241

Buildings and leasehold improvements
1,898

 
2,196

Machinery and equipment, including equipment held for lease
9,542

 
9,464

 
11,530

 
11,901

Accumulated depreciation
(5,819
)
 
(5,847
)
Total
$
5,711

 
$
6,054


Notes Payable and Short-Term Borrowings
Notes payable and short-term borrowings, including the current portion of long-term debt, were as follows:
 
As of
 
January 31, 2020
 
October 31, 2019
 
In millions
Current portion of long-term debt
$
3,399

 
$
3,441

FS commercial paper
696

 
698

Notes payable to banks, lines of credit and other
415

 
286

Total
$
4,510

 
$
4,425



On February 20, 2020, the Company issued $755 million of asset-backed debt securities in six tranches at a weighted average price of 99.99% and a weighted average interest rate of 1.87%, payable monthly from April 2020, $243 million of the asset-backed debt securities have a stated maturity date of March 9, 2021, followed by $512 million with a stated maturity date of February 20, 2030.
Warranties
The Company's aggregate product warranty liability as of January 31, 2020, and changes during the three months then ended were as follows:
 
Three Months Ended
January 31, 2020
 
In millions
Balance at beginning of period
$
400

Charges
67

Settlements made
(77
)
Balance at end of period
$
390


Contract balances
The Company’s contract balances consist of contract assets, contract liabilities, and costs to obtain a contract with a customer.
Contract Assets
A summary of accounts receivable, net, including unbilled receivables was as follows:
 
As of
 
January 31, 2020
 
October 31, 2019
 
In millions
Accounts receivable, net
 
 
 
Accounts receivable
$
2,684

 
$
2,782

Unbilled receivables
218

 
206

Allowance for doubtful accounts
(38
)
 
(31
)
Total
$
2,864

 
$
2,957



Contract Liabilities
Contract liabilities consist of deferred revenue. The aggregate balance of current and non-current deferred revenue was $6.0 billion as of January 31, 2020 and October 31, 2019. During the three months ended January 31, 2020, approximately $1.3 billion of deferred revenue as of October 31, 2019 was recognized as revenue.
Remaining Performance Obligations
Revenue allocated to remaining performance obligations represents contract work that has not yet been performed and does not include contracts where the customer is not committed. Remaining performance obligations estimates are subject to change and are affected by several factors, including contract terminations, changes in the scope of contracts, adjustments for revenue that has not materialized and adjustments for currency.
Remaining performance obligations consist of deferred revenue. As of January 31, 2020, the aggregate amount of remaining performance obligations was $6.0 billion. The Company expects to recognize approximately 42% of this amount as revenue over the remaining fiscal year.
Costs to Obtain a Contract
As of January 31, 2020, the current and non-current portions of the capitalized costs to obtain a contract were $51 million and $77 million, which were included in Other current assets and Long-term financing receivables and other assets, respectively, in the Condensed Consolidated Balance Sheet. For the three months ended January 31, 2020 and 2019, the Company amortized $14 million and $10 million, respectively, of capitalized costs to obtain a contract.